
KCI등재
학술저널
A Case of Ocular Benign Lymphoid Hyperplasia Treated with Bevacizumab Injection
- Doo Hwan Oh Yeoun Sook Chun Jae Chan Kim
- 대한안과학회
- The Korean Journal of Ophthalmology
- Vol.25 No.1
- 등재여부 : KCI등재
- 2011.02
- 57 - 59 (3 pages)
We report the first case of ocular benign lymphoid hyperplasia (BLH) treated with subconjunctival injection of bevacizumab (Avastin). A 27-year-old man presented to our clinic with conjunctival masses and limbal neovascularization. An incisional biopsy yielded the diagnosis of BLH. The patient was subsequently given a subconjunctival injection of bevacizumab (1.25 mg / 0.1 mL). The patient did not experience recurrence or malignant metaplasia during the one-year follow-up period. In patients with conjunctival BLH, subconjunctival injection of bevacizumab can be a useful treatment option in patients unable to undergo a surgical procedure due to limbal neovascularization.
Case Report
Discussion
Conflict of Interest
References